1250 Mesh Silica: Particle Size, Specifications and Common Applications

Published: Source: Silica Raw Materials News Section: Silica Raw Materials

📌 Key Takeaways

  • Topic: Silica for Floor Coatings: Anti-Slip, Matting and Rheology Functions
  • Keywords: silica for refractory
  • Published: 2026-11-20 13:33:28
  • Field: Silica (SiO₂) raw materials · Inorganic non-metallic materials · Chemicals
Akram, Z., Daood, U., Aati, S., Ngo, H. & Fawzy, A. S. Formulation of pH-sensitive chlorhexidine-loaded/mesoporous silica nanoparticles modified experimental dentin adhesive. Mater. Sci. Eng. C. 122, 111894 (2021). Article CAS Google Scholar

Fumed Silica Manufacturer: Production Process, Key Grades and How to Choose

Silica for Rheology Control: How to Select the Right Silica and Dosage
Giannakoudakis, D. A. et al. Improved uranium removal from acidic wastewater by phosphonate-functionalized ordered mesoporous silica: Surface chemistry matters the most. J. Danger. Mater. 413, 125279 (2021). Piece CAS PubMed Google Scholar
What Is Silica Sol? Composition, Acidic vs Alkaline Types and Industrial Applications
Silica Supplier Indonesia: Market Overview and Sourcing Options
Turner, C. T. et al. Delivery of flightless I siRNA from porous silicon nanoparticles improves wound healing in mice. ACS Biomater. Sci. Eng. 2, 2339-2346 (2016). Post CAS PubMed Google Scholar
Spherical Silica Powder: Specifications, Particle Sizes and How to Choose the Right Grade
Yang, X. et al. Platinum nanoenzyme functionalized black phosphorus nanosheets for photothermal and enhanced-photodynamic therapy. Chem. Eng. J. 409, 127381 (2021). Article CAS Google Scholar

What Is Diatomite? Properties, Filtration Uses and Industrial Applications

What is silica (SiO₂)?

highly dispersible silica Due to the essential function of MSNs in the biomedical field, the timeline of some key achievements involving MSNs is presented in Fig. 3. Comparable to MCM-41, Santa Barbara Amorphous-15 (SBA-15) is also demonstrated to be another really promising nanomaterial in the biomedical field, which is a highly stable mesoporous silica sieve reported by scientists from the University of California at Santa Barbara in 1998. 47 Several years later, the first instance of biomedical applications involving mesoporous silica for drug delivery is reported. 48 MCM-41 is revealed to have the talent to load and deliver the anti-inflammatory drug, ibuprofen, with a weight percent ratio of 30%. 48 In the same year, researchers from two different research groups both reported that the particle size of MCM-41 could be tuned to the nanoscale, 49, 50 and its morphology could also be precisely designed. 50 These findings have greatly encouraged researchers to discuss the potential biomedical applications of MSNs. In 2003, Lai et al. explored the feasibility of MCM-41-type MSNs in controlled-release delivery systems, in which they used cadmium sulfide (CdS) NPs as chemically removable caps to encapsulate drug molecules into the pore channels of MSNs. 51 Subsequently, the disulfide bond-reducing molecules served as triggers to control the stimuli-responsive release of drug molecules including vancomycin and adenosine triphosphate. 51 In the meantime, the same research group also utilized polyamidoamines to modify the surface of MCM-41-type MSNs, and constructed a novel gene transfection system in 2004, which is the first study of the uptake behavior about MSNs into the eukaryotic cells. 52 Afterwards, Lin et al. developed fluorescein-labelled hexagonal crystal-like MSNs with a size of 110 nm as cell marker. 53 To fully exploit the physicochemical properties of MSNs and their potential for biomedical applications, in 2008, Liong et al. loaded superparamagnetic iron oxide into the internal pores of MSNs and subjected MSNs to phosphonate coating, targeting ligand modification and anti-cancer drug encapsulation, resulting in a multifunctional silica-based nanoplatform that can be used for imaging, targeting and drug delivery. 54 Since the degradability of MSNs is critical to the growth of nanoformulations with high safety, researchers continue to discuss the degradation behavior and mechanisms of MSNs. In 2010, a three-state degradation process of MSNs was proposed, which presented a new understanding of the degradation kinetic mechanism of MSNs that differs markedly from that of traditional non-porous silica-based materials. 55 Apart from, Lin et al. systematically shown the impact of MSNs with diverse particle size, pore structure and surface modification on hemolytic activity in 2010. 56 This pioneering work delivers advice for understanding the toxic influences of MSNs in vivo. In 2011, Cornell dots, which are silica-based hybrid NPs with a size of 6-10 nm, become the first FDA-approved nanoformulation for a first-in-human clinical trial. 57 The first-in-human clinical trial of 124 I-labelled Cornell dots showed that they can be applied to diagnose and stage tumors including melanoma and malignant brain cancer. 58 Furthermore, to obtain MSNs with rapid biodegradability, Zhao's group developed a biphase stratification method for preparing monodispersed three-dimensional dendritic MSNs (3D-dendritic MSNs). The as-prepared 3D-dendritic MSNs can degrade completely in the simulated biological medium within 24 h. 59 Over the past few years, with the outbreak and spread of coronavirus SARS-CoV-2, nanotechnology based on MSNs against coronavirus infection has also developed. In 2020, Balagna et al. conducted preliminary antiviral test toward SARS-CoV-2 by using the silver nanocluster/silica nanocomposite deposited onto facial masks. 60 In another work, a FDA-approved antiviral drug, niclosamide (NIC), was encapsulated into MSNs, followed by the coating with Tween 60. The MSNs-based nanocomposite was demonstrated to be a potential oral formulation for SARS-CoV-2. 61

What is the difference between fumed silica and precipitated silica?

silicon dioxide covalent network Meng, H. et al. Codelivery of an optimal drug/siRNA combination utilizing mesoporous silica nanoparticles to overcome drug resistance in breast cancer in vitro and in vivo. ACS Nano 7, 994-1005 (2013). Piece CAS PubMed Central PubMed Google Scholar

What drives silica raw material prices?

silicon nitride Gan, Q., Zhu, J., Yuan, Y. & Liu, C. pH-Responsive Fe3O4 nanopartilces-capped mesoporous silica supports for protein delivery. J. Nanosci. Nanotechnol. 16, 5470-5479 (2016). Post CAS PubMed Google Scholar

Cite this article: Silica Raw Materials News. "Silica OEM: How Private-Label and Custom Silica Manufacturing Works ." Published 2026-11-20 13:33:28. /news/article.html
Disclaimer: Prices and data are for reference only and do not constitute purchasing or investment advice. Please credit the source when republishing.